Cellular actions of nociceptin: Transduction mechanisms

Peptides

Volumn 21, Issue 7, 2000, Pages 961-967

  Hawes, Brian E ^a   Graziano, Michael P ^a   Lambert, David G ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

cAMP; Desensitization; Intracellular Ca2+; MAP kinase; Nociceptin; Nociceptin receptor; Signal transduction

Indexed keywords

ADENYLATE CYCLASE; BUPRENORPHINE; CALCIUM ION; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE; NOCICEPTIN; NOCICEPTIN RECEPTOR; OPIATE PEPTIDE; PERTUSSIS TOXIN; PHOSPHOLIPASE C;

ANIMAL CELL; CALCIUM CELL LEVEL; CELL LINE; HUMAN; HUMAN CELL; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR ACTIVATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033817778     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00232-1     Document Type: Article

References (71)

1. 2-adrenergic receptors expressed in fibroblasts. J Biol Chem. 268:1993;22235-22238.
2. 2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br J Pharmacol. 126:1999;555-558.
3. Blenis J. Signal transduction via MAP kinases proceed at your own RSK . Proc Natl Acad Sci USA. 90:1993;5889-5892.
4. Butour J.L., Moisand C., Mazarguil H., Mollereau C., Meunier J.C. Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids. Eur J Pharmacol. 321:1997;97-103.
5. Buzas B., Rosenberger J., Cox B.M. Activity and cyclic AMP-dependent regulation of nociceptin/orphanin FQ gene expression in primary neuronal and astrocyte cultures. J Neurochem. 71:1998;556-563.
6. Calo' G., Guerrini R., Bigoni R., Rizzi A., Marzola G., Okawa H., Bianchi C., Lambert D.G., Salvadori S., Regoli D. Characterisation of [Nphe1]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist. Br J Pharmacol. 129:2000;1183-1193.
7. 16 proteins . J Neurochem. 71:1998;2203-2210.
8. Cheng Z.-J., Fan G.-H., Zhao J., et al. Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells activation of inhibitory G protein and homologous desensitisation . NeuroReport. 8:1997;1913-1918.
9. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol. 119:1996;1614-1618.
10. 2+ in the SH-SY5Y human neuroblastoma cell line. Br J Pharmacol. 118:1996;205-207.
11. Crespo P., Xu N., Simonds W.F., Gutkind J.S. Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature (London). 369:1994;418-420.
12. ras in activation of extracellular signal-regulated kinase 2. Nature (London). 357:1992;602-604.
13. Dikic I., Tokiwa G., Lev S., Courtneidge S.A., Schlessinger J. A role for Pyk2 and Src in llinking G-protein-coupled receptors with MAP kinase activation. Nature (London). 383:1996;547-550.
14. Dooley C.T., Spaeth C.G., Berzetei-Gurske I.P., et al. Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J Pharmacol Exp Ther. 283:1997;735-741.
15. Faber E.S.L., Chambers J.P., Evans R.H., Henderson G. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br J Pharmacol. 119:1996;189-190.
16. Faure M., Voyno-Yasenetskaya T.A., Bourne H.R. cAMP, and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem. 269:1994;7851-7854.
17. Fawzi A.B., Zhang H., Weig B., Hawes B., Graziano M.P. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells functional homology with opioid receptors . Eur J Pharmacol. 336:1997;233-242.
18. Gilman A.G. G proteins transducers of receptor-generated signals . Annu Rev Biochem. 56:1987;615-649.
19. Giuliani S., Maggi C.A. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br J Pharmacol. 118:1996;1567-1569.
20. Grisel J.E., Mogil J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not spinal, anti-opioid peptide. NeuroReport. 7:1996;2125-2129.
21. Gutkind J.S. The pathways connecting G-proteincoupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem. 273:1998;1839-1842.
22. Hamm H.E. The many faces of G protein signaling. J Biol Chem. 273:1998;669-672.
23. Harrison C., Smart D., Lambert D.G. Stimulatory effects of opioids. Br J Anaesthesia. 81:1998;20-28.
24. Hashimoto Y., Lambert D.G. Studies on the desensitisation of human recombinant nociceptin receptors expressed in Chinese hamster ovary cells. Br J Pharmacol. 128:1999;176P.
25. i-coupled signaling pathway Evidence for distinct mechanisms of agonist-mediated desensitization . J Neurochem. 71:1998;1024-1033.
26. Hawes B.E., Luttrell L.M., van Biesen T., Lefkowitz R.J. Phosphatidylinositol 3-kinase is an early intermediate in the Gβγ-mediated mitogen-activated protein kinase signaling pathway. J Biol Chem. 271:1996;12133-12136.
27. q-mediated mitogen-activated protein kinase activation. J Biol Chem. 270:1995;17148-17153.
28. Helyes Z., Nemeth J., Pinter E., Szolcsanyi J. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br J Pharmacol. 121:1997;613-615.
29. i signalling in SH-SY5Y human neuroblastoma cells. Br J Pharmacol. 120:1997;224P.
30. Howe L.R., Leevers S.J., Gomez N., Nakielny S., Cohen P., Marshall C.J. Activation of the MAP kinase pathway by the protein kinase raf. Cell. 71:1992;335-342.
31. Ingram S.L., Williams J.T. Opioid inhibition of Ih via adenylyl cyclase. Neuron. 13:1994;179-186.
32. Ingram S.L., Williams J.T. Modulation of the hyperpolarization-activated current (Ih) by cyclic nucleotides in guinea-pig primary afferent neurons. J Physiol (London). 492:1996;97-106.
33. Knoflach F., Reinscheid R.K., Civelli O., Kemp J.A. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J. Neurosci. 16:1996;6657-6664.
34. ras. Proc Natl Acad Sci USA. 91:1994;12706-12710.
35. Koch W.J., Hawes B.E., Inglese J., Luttrell L.M., Lefkowitz R.J. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates Gβγ-mediated signaling. J Biol Chem. 269:1994;6193-6197.
36. Leevers S.J., Paterson H.F., Marshall C.J. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature (London). 369:1994;411-414.
37. Lev S., Moreno H., Martinez R., et al. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature (London). 376:1995;737-745.
38. Lopez-Ilasaca M., Crespo P., Pellici P.G., Gutkind J.S., Wetzker R. Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase γ Science. 275:1997;394-397.
39. 2+ pathway. Biochem Biophys Res Commun. 240:1997;304-308.
40. Ludwig A., Zong X., Jeglitsch M., Hofmann F., Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature (London). 393:1998;587-591.
41. Luttrell L.M., Hawes B.E., van Biesen T., Luttrell D.K., Lansing T., Lefkowitz R.J. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gβγ-mediated activation of mitogen activated protein kinases. J Biol Chem. 271:1996;19443-19450.
42. Ma L., Cheng Z.-J., Fan G.-H., Cai Y.-C., Jiang L.-Z., Pei G. Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma X glioma NG108-15 hybrid cells. FEBS Lett. 403:1997;91-94.
43. Matthes H., Seward E.P., Kieffer B., North R.A. Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes. Mol Pharmacol. 560:1996;447-450.
44. Meunier J.-C., Mollereau C., Toll L., et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature (London). 377:1995;532-535.
45. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., Grandy D.K. Functional antagonism of μ, δ, and κ-opioid antinociception by orphanin FQ. Neurosci Lett. 214:1996;131-134.
46. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
47. Murphy N.P., Ly H.T., Maidment N.T. Intracerebroventricular orphanin FQ nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetised rats. Neuroscience. 75:1996;1-4.
48. Neal M.J., Cunningham J.R., Paterson S.J., Mcknight A.T. Inhibition by nociceptin of the light-evoked release of Ach from retinal cholinergic neurones. Br J Pharmacol. 120:1997;1399-1400.
49. Neer E. Heterotrimeric G proteins. Organizers of transmembrane signaling. Cell. 80:1995;249-257.
50. + evoked glutamate release from rat cerebrocortical slices. Br J Pharmacol. 119:1996;1081-1083.
51. Nicol B., Okawa H., Rowbotham D.J., Lambert D.G. Effects of naloxone benzoylhydrazone (NalBzOH) on nociceptin signalling in rat brain and CHO cells expressing recombinant nociceptin receptors. Regul Pept. 80:1999;125.
52. Okawa H., Hirst R.A., Smart D., McKnight A.T., Lambert D.G. Rat central ORL-1 receptor uncouples from adenylyl cyclase during membrane preparation. Neurosci Lett. 246:1998;49-52.
53. 2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors. Br J Pharmacol. 127:1999;123-130.
54. Patel H.J., Giembycz M.A., Spicuzza L., Barnes P.J., Belvisi M.G. Naloxone-insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by the novel opioid, nociceptin. Br J Pharmacol. 120:1997;735-736.
55. Reinscheid R.K., Ardati A., Monsma F.J. Jr, Civelli O. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem. 271:1996;14163-14168.
56. Reinscheid R.K., Nothacker H.-P., Bourson A., et al. Orphanin FQ a neuropeptide that activates an opioid like G protein-coupled receptor . Science. 270:1995;792-794.
57. Saito Y., Maruyama K., Kawano H., et al. Molecular cloning and characterization of a novel form of neuropeptide gene as a developmentally regulated molecule. J Biol Chem. 271:1996;15615-15622.
58. Schlicker E., Werthwein S., Kathmann M., Bauer U. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. N S Arch Pharmacol. 358:1998;418-422.
59. Sim L.J., Xiao R., Childers S.R. Identification of opioid receptor-like (ORL1) peptide-stiumulated [35S]GTP gamma S binding in rat brain. NeuroReport. 7:1996;729-733.
60. Simon M.I., Strathmann M., Gautam N. Diversity of G proteins in signal transduction. Science. 252:1991;802-808.
61. Smart D., Lambert D.G. Mechanisms of the stimulatory effects of opioids and their potential role in the development of tolerance. Trends Pharmacol Sci. 17:1996;264-269.
62. Tian J.-H., Xu W., Fang Y., et al. Bidirectional modulatory effect of orphanin FQ on morphine induced analgesia antangonism in brain and potentiation in spinal cord of the rat . Br J Pharmacol. 120:1997;676-680.
63. van Biesen T., Hawes B.E., Luttrell D.K., et al. Receptor-tyrosine-kinase-, and Gβγ-mediated MAP kinase activation by a common signaling pathway. Nature (London). 376:1995;781-784.
64. o-protein α-subunits activate mitogen-activated protein kinase via a novel protein kinase C-dependent mechanism. J Biol Chem. 271:1996;1266-1269.
65. van Biesen T., Luttrell L.M., Hawes B.E., Lefkowitz R.J. Mitogenic signaling via G protein-coupled receptors. Endocr Rev. 17:1996;698-714.
66. van Corven E.J., Groenink A., Jalink K., Eichholtz T., Moolenaar W.H. Lysophosphatidate-induced cell proliferation Identification and dissection of signaling pathways mediated by G proteins . Cell. 59:1989;45-54.
67. ras by G protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci USA. 90:1993;1257-1261.
68. + conductance in dorsal raphe nucleus neurons. Br J Pharmacol. 117:1996;1609-1611.
69. Vaughan C.W., Ingram S.L., Christie M.J. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray in vitro. J Neurosci. 17:1997;996-1003.
70. i-coupled Acetylcholine muscarinic m2 receptor activation of mitogen-activated protein (MAP) kinase kinase and MAP kinase. J Biol Chem. 268:1993;19196-19199.
71. Xu X.J., Hao J.X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin potent antinociceptive effect of orphanin FQ/nociceptin in the rat . NeuroReport. 7:1996;2092-2094.